AcceleratorBlack Flag is a virtual accelerator that provides capital and hands-on support to early-stage companies developing critical technologies in sectors such as aerospace, biology, energy, and robotics.
Loading

PharmStars is a Boston-based accelerator focused on connecting digital health startups with pharmaceutical companies to enhance patient outcomes. It offers a structured 10-week program that includes tailored education and mentoring.
Online destinations
Public destinations are grouped by their documented relationship to the organization. A listed link does not by itself prove ownership or control.
Destinations the organization presents as part of its public presence.
PharmStars is a pharma-focused accelerator for digital health startups, founded to bridge the gap between digital health innovations and pharmaceutical companies. Based in Boston, Massachusetts, PharmStars is dedicated to enhancing patient outcomes through the adoption of digital health solutions. The accelerator provides a structured program that prepares startups to engage effectively with the pharma industry.
PharmStars specializes in accelerating digital health startups that seek to engage with pharma and biotech firms. The program focuses on startups with digital innovations that can enhance operational efficiencies or improve scientific and clinical outcomes. It offers tailored education and mentoring to help startups develop compelling value propositions for the pharmaceutical industry.
PharmStars offers a comprehensive accelerator program that includes a 10-week PharmaU curriculum, mentoring from industry experts, and access to a members-only Startup Showcase for one-on-one meetings with pharma representatives. Graduates receive a $100,000 SAFE investment from PharmStars Ventures Fund, along with tailored support to refine their business strategies for the pharmaceutical market.
Q: What is the application process for PharmStars? A: Startups can apply through the application form available on the PharmStars website. Q: What is the focus of the upcoming cohorts? A: The Fall 2026 cohort will focus on Digital Innovations in Immunology. Q: What support do startups receive? A: Startups receive mentoring, education, and access to pharma partners to enhance their market readiness.
Superscout Pro

Superscout documents PharmStars independently from canonical records and linked sources. Missing facts stay missing.
Last reviewed .
Terms, dates, and eligibility can change. Confirm time-sensitive details with the original source.
Stage and region classifications are shown as recorded. Broad labels such as “Global” and category-like stage labels may still need normalization.
Superscout is not affiliated with, endorsed by, or acting on behalf of the organizations documented here.